Hostname: page-component-848d4c4894-ndmmz Total loading time: 0 Render date: 2024-05-20T05:58:42.664Z Has data issue: false hasContentIssue false

Parkinsonism with Neuroacanthocytosis

Published online by Cambridge University Press:  18 September 2015

R.F. Peppard
Affiliation:
Department of Medicine, University of British Columbia, Vancouver
C.S. Lu
Affiliation:
Department of Neurology, Chang Gung Memorial Hospital, Taipei, Taiwan, R.O.C.
Nai-Shin Chu
Affiliation:
Department of Neurology, Chang Gung Memorial Hospital, Taipei, Taiwan, R.O.C.
P. Teal
Affiliation:
Department of Medicine, University of British Columbia, Vancouver
W.R.W. Martin
Affiliation:
Department of Medicine, University of British Columbia, Vancouver
D.B. Calne*
Affiliation:
Department of Medicine, University of British Columbia, Vancouver
*
Division of Neurology, University Hospital, 2211 Wesbrook Mall, U.B.C., Vancouver, British Columbia, Canada V6T 1W5
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Two patients with neuroacanthocytosis are described. One presented with parkinsonism and the other resembled diurnal dystonia of the Segawa type. Both patients responded well to dopaminomimetic therapy. A PET scan with fluorodopa revealed a nigrostriatal deficit in the first patient.

Résumé:

RÉSUMÉ:

Nous décrivons deux patients avec neuro-acanthocytose. Un des patients s'est présenté avec du parkinsonisme et l'autre avec une dystonie diurne de type Segawa. Les deux patients ont bien répondu à la thérapie dopaminomimétique. Un PET scan à la fluorodopa a révélé un déficit nigrostrié chez le premier patient.

Type
Original Articles
Copyright
Copyright © Canadian Neurological Sciences Federation 1990

References

REFERENCES

1. Bassen, FA, Kornzweig, AL. Malformation of the erythrocytes in a case of atypical retinitis pigmentosa. Blood 1950; 5: 381387.Google Scholar
2. Mars, H, Lewis, LA, Robertson, AL, et al. Familial hypolipoproteinemia: a genetic disorder of lipid metabolism with nervous system involvement. Am J Med 1969; 46: 886900.CrossRefGoogle ScholarPubMed
3. Critchley, EMR, Clark, DB, Wikler, A. Acanthocytosis and neurological disorder without betalipoproteinemia. Ann Neurol 1968; 18: 134140.Google Scholar
4. Levine, IM, Estes, JW, Looney, JM. Hereditary neurological disease with acanthocytosis. Arch Neurol 1968; 19: 403409.Google Scholar
5. Aminoff, MJ. Acanthocytosis and neurological disease. Brain 1972; 95:749760.Google Scholar
6. Williams, WJ, Beutler, E, Erslev, AJ, et al. Hematology. 3rd Edition. McGraw-Hill 1983; 556559.Google Scholar
7. Pittiglio, DH, Sacher, RA. Clinical hematology and fundamentals of hemostasis. F.A. Davis & Co. 1987; 396397.Google Scholar
8. Clark, MR, Aminoff, MJ, Chiu, DT-Y, et al. Red cell defonnability and lipid composition in two forms of acanthocytosis: enrichment of acanthocytic populations by density gradient centrifugation. J Lab Clin Med 1989; 113: 468481.Google ScholarPubMed
9. Hardie, RJ. Acanthocytosis and neurological impairment - a review. Quat J Med 1989; 264: 291306.Google Scholar
10. Calne, DB, Langston, JW, Martin, WRW, et al. Positron emission tomography after MPTP: observations relating to the cause of Parkinson’s disease. Nature 1985; 317: 246248.Google Scholar
11. Bruyn, GW. Chorea-acanthocytosis. In: Vinken, RJ, Bruyn, GW, Klawans, HL, eds. Extrapyramidal disorders. Handbook of Clinical Neurology; vol. 49. Amsterdam: Elsevier Science Publishers 1986; 327334.Google Scholar
12. Swash, M, Schwartz, MS, Carter, ND, et al. Benign X-linked myopathy with acanthocytes (McLeod syndrome). Brain 1983; 106: 717733.Google Scholar
13. Jankovic, J, Killian, JM, Spitz, MC. Neuroacanthocytosis syndrome and choreoacanthocytosis (Levine-Critchley syndrome). Neurology 1985; 35: 1679.Google Scholar
14. Sakai, T, Mawatari, S, Iwashita, H, et al. Choreoacanthocytosis: clues to clinical diagnosis. Arch Neurol 1981; 38: 335338.Google Scholar
15. Kondo, K, Yanagisawa, N. Familial chorea with neuropathy and acanthocytosis: report of six cases with special reference to its clinical variety. Neurol Med Chir (Tokyo) 1981; 15: 118127.Google Scholar
16. Yamamoto, T, Hirose, G, Shimazaki, K, et al. Movement disorders of familial neuroacanthocytosis syndrome. Arch Neurol 1982; 39: 298301.Google Scholar
17. Ohnishi, N, Sato, Y, Nagara, H, et al. Neurogenic muscular atrophy and low density of large myelinated fibres of sural nerve in chorea-acanthocytosis. J Neurol Neurosurg Psychiatry 1981; 44: 645648.Google Scholar
18. Limos, LC, Ohnishi, A, Sakai, T, et al. “Myopathic” changes in chorea-acanthocytosis. J Neurol Sci 1982; 55: 4958.Google Scholar
19. Spitz, MC, Jankovic, J, Killian, JM. Familial tic disorder, parkinsonism, motor neuron disease, and acanthocytosis: a new syndrome. Neurology 1985; 35: 366370.Google Scholar
20. Segawa, M, Hosaka, A. Miyagawa, F, et al. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 1976; 14: 215233.Google Scholar
21. Bird, TD, Cederbaum, S, Valpey, RW, et al. Familial degeneration of the basal ganglia with acanthocytosis: a clinical, neuropathological and neurochemical study. Ann Neurol 1978; 3: 253258.Google Scholar
22. Sato, Y, Ohmishi, A, Teteinshi, J. An autopsy case of chorea-acanthocytosis. NoToShinkei 1984; 365: 105111.Google Scholar
23. Spencer, SE, Walker, FO, Moore, SA. Chorea-amyotrophy with chronic hemolytic anemia: a variant of chorea-acanthocytosis. Neurology 1987; 37: 645649.Google Scholar